The government has so far paid Emergent BioSolutions $271 million, even though American regulators have yet to clear a single dose of vaccine produced at its manufacturing plant in Baltimore.
What to Expect from a Potential Trump Administration in 2025
As Donald Trump campaigns for a potential return to the presidency, speculation grows about what his administration might prioritize and how it would shape the
